Long-term Outcome of Treatment of Mycobacterium Abscessus Pulmonary Disease

Background: Although there is an increasing incidence of Mycobacterium abscessus pulmonary disease in Korea, the optimal therapeutic regimen has not yet been established and there are no reports of the long-term treatment outcomes. This study examined the long-term treatment outcomes of M. abscessus pulmonary disease. Methods: Twenty-nine patients diagnosed with M. abscessus pulmonary according to the American Thoracic Society criteria and treated from January 1996 to December 2003 were enrolled in ghis study. The clinical characteristics, radiological findings, treatment outcome, and follow up data were analyzed retrospectively. Results: The mean age of the 29 patients was 56.1 (± 13.6) years and there was a female (22/29) dominance. The chest radiography revealed the nodular bronchiectatic type to be dominant (69%, 20/29). Twenty-seven (93.1%) were prescribed clarithromycin-containing regimens, and injectable drugs, mainly aminoglycosides, were included in the regimen of nineteen patients. The most predominant regimen (48.3%) consisted of clarithromycin and amikacin. The treatment success, failure, and default were achieved in 19(65.5%), 9(31.0%), and 1(3.4%), respectively. The median duration to culture conversion was 42 days (range 15-362) and the median duration of treatment in the success group was 543 days (range 176-1,160). An adjunctive surgical resection was performed in five patients, which resulted in treatment success in two patients. After the completion of treatment, nineteen patients were followed up for a median duration of 931 days (range 230-2,294). Only one (5.3%) patient relapsed 45 days after completing treatment. Conclusion: Treatment with clarithromycin-containing regimens resulted in a successful treatment in approximately two thirds of patients with M. abscessus pulmonary disease. The long-term relapse rate was also quite low. (Tuberc Respir Dis 2007; 62: 98-104)

keywords: Mycobacterium abscessus pulmonary disease, Treatment outcome, Long term result., Mycobacterium abscessus pulmonary disease, Treatment outcome, Long term result.

Reference

(1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria,

(2000) Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999,

(1998) Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months antimycobacterial therapy combined with highly active antiretroviral therapy,

Infection with Mycobacterium avium complex in patients without predisposing conditions, Prince DS

(2003) Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens,

(2005) Recovery rate and characteristics of nontuberculous mycobacterial isolates in a university hospital in Korea,

(2002) Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria,

(2002) Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients,

(2004) Treatment of nontuberculous mycobacterial pulmonary disease,

10.

(2003) Clinical manifestations of pulmonary infection due to rapidly growing nontuberculous mycobacteria,

11.

(2003) The treatment outcome of Mycobacterium abscessus pulmonary disease ,

12.

(2000) Diagnostic standards and classification of tuberculosis in adults and children,

13.

(2000) Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene,

14.

(2004) Treatment of Mycobacterium avium complex (MAC) pulmonary disease,

15.

(2000) Tuberculosis surveillance system in Korea,

16.

(1999) Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease,

17.

(2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis,

18.

(amrevrespirdis1993;147) Clinical features of pulmonary disease caused by rapidly growing mycobacteria an analysis of 154 patients,

19.

(2001) The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment,

20.

(2003) Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes, NCCLS, Wayne, Pa

바로가기메뉴

Article Contents

Vol.62 No.2

Long-term Outcome of Treatment of Mycobacterium Abscessus Pulmonary Disease

Abstract

Reference

Tuberculosis & Respiratory Diseases